Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease

BACKGROUND: Glioblastoma (GB) is the most common malignant brain tumor with a dismal prognosis despite standard of care (SOC). Here we used a network meta-analysis on treatments from randomized control trials (RCTs) to assess the effect on overall survival (OS) and progression-free survival (PFS) be...

Descripción completa

Detalles Bibliográficos
Autores principales: Taslimi, Shervin, Ye, Vincent C, Zadeh, Gelareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134529/
https://www.ncbi.nlm.nih.gov/pubmed/34042102
http://dx.doi.org/10.1093/noajnl/vdab028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134529/
https://www.ncbi.nlm.nih.gov/pubmed/34042102
http://dx.doi.org/10.1093/noajnl/vdab028

Ejemplares similares